European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
Robert Knobler(Medical University of Vienna), Thomas Krieg(University of Cologne), Ivan Foeldvari(Schön Klinik Hamburg Eilbek), Vanessa Smith(Ghent University Hospital), Jaana Panelius(University of Helsinki), Michael Sticherling(Hochschule für Angewandte Wissenschaften Kiel), Maurizio Cutolo(Ospedale Policlinico San Martino), C. Françès(Sorbonne Université), Cord Sunderkötter(University Hospital in Halle), G. Bali(Semmelweis University), Veli‐Matti Kähäri(University of Turku), Alain Taı̈eb(Hôpital Saint-André), Ahmad Jalili(Medical University of Vienna), L.A. Frasin(Alessandro Manzoni Hospital), Nicolas Hunzelmann(University Hospital Cologne), Margitta Worm(Freie Universität Berlin), Ulrike Just(Medical University of Vienna), Dorota Krasowska(Medical University of Lublin), Lidia Rudnicka(Medical University of Warsaw), Peter Wolf(Medical University of Graz), Pietro Quaglino(Department of Medical Sciences), Anna Skrok(Medical University of Warsaw), M. Bagot, Adrian Tanew(Medical University of Vienna), Pia Moinzadeh(University Hospital Cologne), Klaus F. Kofoed(Gentofte Hospital), Annamari Ranki(University of Helsinki), Jean‐David Bouaziz(Hôpital Saint-Louis), Małgorzata Olszewska(Medical University of Warsaw), Julien Sénéschal(Université de Bordeaux), Alexander Kreuter(HELIOS St. Elisabeth Klinik Oberhausen), Franco Rongioletti(University of Cagliari), Elisabeth Aberer(Medical University of Graz), Aurora Parodi(Ospedale Policlinico San Martino), Anne Braae Olesen(Aarhus University Hospital), Christopher P. Denton(The Royal Free Hospital), A. Petit(Hôpital Saint-Louis), Antonio Cozzio(Kantonsspital St. Gallen), Nora Wutte(Medical University of Graz), J Schmidt(Universitat Autònoma de Barcelona), Luc Mouthon(Centre National de la Recherche Scientifique), Catherine H. Orteu(The Royal Free Hospital), Sarolta Kárpáti(Semmelweis University)
Cited by 261
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
World Allergy Organization Anaphylaxis Guidance 2020
|World Allergy Organization Journal|2020|1.1k